Emperra's Bluetooth insulin pen and smartphone app in last CE approval stages - European Pharmaceutical Manufacturer

Emperra GmbH E-Health Technologies has announced that its integrated telemonitoring system — comprising of Bluetooth-enabled ESYSTA smart insulin pen and diabetes smartphone app — is almost ready for market launch.

PDF) The Review of Insulin Pens—Past, Present, and Look to the Future

PDF) Clinical, Economic, and Patient-Reported Benefits of

Companion Medical InPen Cleared for Use on Android & In Europe

Smart Insulin Pens Market Top Companies

Sanofi secures US regulatory approval for new insulin pen

BTPEN1 ESYSTA BT Pen User Manual 15_ESYSTA BT Pen B and W UserMan

Emerging Diabetes Technologies: Continuous Glucose Monitors

BTPEN1 ESYSTA BT Pen User Manual 15_ESYSTA BT Pen B and W UserMan

Companion Medical Announces US Commercial Launch of Smart Insulin